세계의 독성 약물 스크리닝 시장 보고서(2025년)

Toxicology drug screening is a process designed to detect drugs, chemicals, or their metabolites in biological samples such as urine, blood, saliva, or hair. This type of medical testing is frequently utilized to identify both legal and illegal substances present in a person's system. Its primary purpose is to determine and assess drug exposure in an individual, serving a variety of needs depending on the application context.

Toxicology drug screening encompasses several major types, including monitoring and logging, security, storage, continuous integration or deployment, management and orchestration, networking, data management services, and others. Monitoring and logging refer to the ongoing tracking and documentation of data derived from tests and related activities. This category involves multiple test types such as acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity. It also incorporates advanced technologies like high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening. Applications include immunotoxicity, systemic toxicity, developmental and reproductive toxicity (DART), endocrine disruption, among others. The end users of these screenings span across hospitals, clinics, contract research organizations (CROs), pharmaceutical firms, and workplace drug testing centers.

The toxicology drug screening market research report is one of a series of new reports from The Business Research Company that provides toxicology drug screening market statistics, including toxicology drug screening industry global market size, regional shares, competitors with a toxicology drug screening market share, detailed toxicology drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the toxicology drug screening industry. This toxicology drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The toxicology drug screening market size has grown strongly in recent years. It will grow from $19.56 billion in 2024 to $21.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The historical growth is driven by increasing instances of drug misuse, the introduction of workplace drug testing regulations, a rise in toxicology testing in athletic settings, the expansion of forensic toxicology capabilities, and the growing use of toxicology analysis in criminal investigations.

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $30.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Contributing factors to this future growth include the surge in personalized medicine approaches, heightened regulatory emphasis on drug safety, an uptick in the usage of cannabis and synthetic substances, broader healthcare infrastructure development in developing countries, and the increasing prevalence of substance abuse. Key trends projected during this period involve innovations in high-throughput screening tools, enhanced use of artificial intelligence in toxicology analytics, the emergence of point-of-care toxicology diagnostics, progress in biomarker-driven screening techniques, and improved automation and robotic systems in drug screening workflows.

The increasing prevalence of drug abuse is anticipated to drive the growth of the toxicology drug screening market. Drug abuse refers to the harmful or excessive consumption of drugs for non-medical purposes, which adversely affects an individual's health and well-being. The rise in drug abuse is attributed to growing stress and mental health issues, prompting many to use substances as a coping mechanism. Toxicology drug screening plays a crucial role in detecting the presence of drugs or their metabolites in the body, facilitating early identification, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, reflecting a 12% increase (121 additional deaths) compared to 2022. As a result, the rising incidence of drug abuse is contributing to the expansion of the toxicology drug screening market.

Leading companies in the toxicology drug screening market are introducing innovative solutions such as forensic toxicology screening to improve the accuracy and speed of substance detection in clinical, forensic, and workplace environments. Forensic toxicology screening involves the examination of biological samples to identify drugs, poisons, or toxins associated with criminal investigations, accidents, or fatalities. For instance, in June 2022, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, launched the ToxSpec Analyzer, a comprehensive LC-MS (liquid chromatography-mass spectrometry) system designed for clinical and forensic toxicology applications. This solution combines hardware, software, and validated methods to automate and optimize drug analyte screening, making the technology accessible even to labs with limited experience in LC-MS/MS. The ToxSpec Analyzer enhances operational efficiency, boosts identification accuracy, and allows laboratories to add new compounds as needed.

In September 2024, Scantox Group, a preclinical contract research organization based in Denmark that specializes in toxicology testing, acquired Gentronix for an undisclosed sum. The acquisition is intended to strengthen Scantox Group's early toxicity testing capabilities by incorporating Gentronix's expertise in genetic toxicology and predictive safety evaluation, thereby broadening its services for the pharmaceutical and chemical sectors. Gentronix, headquartered in the UK, is a preclinical contract research organization offering toxicology services, including drug screening.

Major players in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, and Alere Inc.

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in toxicology drug screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the toxicology drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The toxicology drug screening market consists of revenues earned by entities by providing services, such as pre-employment drug testing, sports drug testing, confirmatory testing, addiction treatment monitoring, and pain management monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Toxicology Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on toxicology drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for toxicology drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The toxicology drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Monitoring And Logging; Security; Storage And Continuous Integration Or Continuous Deployment; Management And Orchestration; Networking And Data Management Services; Other Types
• 2) By Test Type: Acute Systemic Toxicity; Dermal Toxicity; Carcinogenicity; Ocular Toxicity; Genotoxicity; Neurotoxicity; Organ-Specific Toxicity
• 3) By Technology Type: High-Throughput Screening; Genomics; Transcriptomics; Toxicogenomics; Molecular Screening
• 4) By Application: Immunotoxicity; Systemictoxicity; Developmental And Reproductive Toxicity (DART); Endocrine Disruption; Other Applications
• 5) By End Users: Hospitals; Clinics; Contract Research Organizations (CROs); Pharmaceutical Companies; Workplace Testing Facilities
• Subsegments:
• 1) By Monitoring And Logging: Real-Time Drug Monitoring Systems; Bioanalytical Instrumentation Logs; Toxicity Alert Notification Systems; Compliance And Audit Trail Monitoring
• 2) By Security: Data Encryption Solutions For Lab Reports; Access Control Systems For Toxicology Data; Secure Sample Tracking Systems; HIPAA Or GDPR-Compliant Drug Testing Platforms
• 3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions; Automated Toxicology Report Generation Pipelines; LIMS (Laboratory Information Management Systems) Integration Tools; Version Control For Test Protocols And Databases
• 4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs; Centralized Dashboard For Drug Screening Management; Multi-Site Test Scheduling And Coordination Platforms; Vendor Management Systems For Lab Supplies
• 5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange; Toxicology Data Integration Services With EHR/EMR Systems; Remote Access For Toxicology Results And Analysis; Data Warehousing For Toxicology And Screening Records
• 6) By Other Types: AI-Powered Predictive Toxicology Platforms; Mobile Drug Screening Applications; Blockchain-Based Chain Of Custody Solutions; Voice And Image Recognition Tools In Toxicology
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Toxicology Drug Screening Market Characteristics

3. Toxicology Drug Screening Market Trends And Strategies

4. Toxicology Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Toxicology Drug Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Toxicology Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Toxicology Drug Screening Market Growth Rate Analysis
• 5.4. Global Toxicology Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Toxicology Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Toxicology Drug Screening Total Addressable Market (TAM)

6. Toxicology Drug Screening Market Segmentation

• 6.1. Global Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monitoring And Logging
• Security
• Storage And Continuous Integration Or Continuous Deployment
• Management And Orchestration
• Networking And Data Management Services
• Other Types
• 6.2. Global Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Systemic Toxicity
• Dermal Toxicity
• Carcinogenicity
• Ocular Toxicity
• Genotoxicity
• Neurotoxicity
• Organ-Specific Toxicity
• 6.3. Global Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Throughput Screening
• Genomics
• Transcriptomics
• Toxicogenomics
• Molecular Screening
• 6.4. Global Toxicology Drug Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunotoxicity
• Systemictoxicity
• Developmental And Reproductive Toxicity (DART)
• Endocrine Disruption
• Other Applications
• 6.5. Global Toxicology Drug Screening Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Contract Research Organizations (CROs)
• Pharmaceutical Companies
• Workplace Testing Facilities
• 6.6. Global Toxicology Drug Screening Market, Sub-Segmentation Of Monitoring And Logging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Drug Monitoring Systems
• Bioanalytical Instrumentation Logs
• Toxicity Alert Notification Systems
• Compliance And Audit Trail Monitoring
• 6.7. Global Toxicology Drug Screening Market, Sub-Segmentation Of Security, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Encryption Solutions For Lab Reports
• Access Control Systems For Toxicology Data
• Secure Sample Tracking Systems
• HIPAA Or GDPR-Compliant Drug Testing Platforms
• 6.8. Global Toxicology Drug Screening Market, Sub-Segmentation Of Storage And Continuous Integration Or Continuous Deployment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Sample Data Storage Solutions
• Automated Toxicology Report Generation Pipelines
• LIMS (Laboratory Information Management Systems) Integration Tools
• Version Control For Test Protocols And Databases
• 6.9. Global Toxicology Drug Screening Market, Sub-Segmentation Of Management And Orchestration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Workflow Automation Tools For Toxicology Labs
• Centralized Dashboard For Drug Screening Management
• Multi-Site Test Scheduling And Coordination Platforms
• Vendor Management Systems For Lab Supplies
• 6.10. Global Toxicology Drug Screening Market, Sub-Segmentation Of Networking And Data Management Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interoperability Platforms For Healthcare Data Exchange
• Toxicology Data Integration Services With EHR/EMR Systems
• Remote Access For Toxicology Results And Analysis
• Data Warehousing For Toxicology And Screening Records
• 6.11. Global Toxicology Drug Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Powered Predictive Toxicology Platforms
• Mobile Drug Screening Applications
• Blockchain-Based Chain Of Custody Solutions
• Voice And Image Recognition Tools In Toxicology Workflows

7. Toxicology Drug Screening Market Regional And Country Analysis

• 7.1. Global Toxicology Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Toxicology Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Toxicology Drug Screening Market

• 8.1. Asia-Pacific Toxicology Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Toxicology Drug Screening Market

• 9.1. China Toxicology Drug Screening Market Overview
• 9.2. China Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Toxicology Drug Screening Market

• 10.1. India Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Toxicology Drug Screening Market

• 11.1. Japan Toxicology Drug Screening Market Overview
• 11.2. Japan Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Toxicology Drug Screening Market

• 12.1. Australia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Toxicology Drug Screening Market

• 13.1. Indonesia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Toxicology Drug Screening Market

• 14.1. South Korea Toxicology Drug Screening Market Overview
• 14.2. South Korea Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Toxicology Drug Screening Market

• 15.1. Western Europe Toxicology Drug Screening Market Overview
• 15.2. Western Europe Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Toxicology Drug Screening Market

• 16.1. UK Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Toxicology Drug Screening Market

• 17.1. Germany Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Toxicology Drug Screening Market

• 18.1. France Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Toxicology Drug Screening Market

• 19.1. Italy Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Toxicology Drug Screening Market

• 20.1. Spain Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Toxicology Drug Screening Market

• 21.1. Eastern Europe Toxicology Drug Screening Market Overview
• 21.2. Eastern Europe Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Toxicology Drug Screening Market

• 22.1. Russia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Toxicology Drug Screening Market

• 23.1. North America Toxicology Drug Screening Market Overview
• 23.2. North America Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Toxicology Drug Screening Market

• 24.1. USA Toxicology Drug Screening Market Overview
• 24.2. USA Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Toxicology Drug Screening Market

• 25.1. Canada Toxicology Drug Screening Market Overview
• 25.2. Canada Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Toxicology Drug Screening Market

• 26.1. South America Toxicology Drug Screening Market Overview
• 26.2. South America Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Toxicology Drug Screening Market

• 27.1. Brazil Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Toxicology Drug Screening Market

• 28.1. Middle East Toxicology Drug Screening Market Overview
• 28.2. Middle East Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Toxicology Drug Screening Market

• 29.1. Africa Toxicology Drug Screening Market Overview
• 29.2. Africa Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Toxicology Drug Screening Market Competitive Landscape And Company Profiles

• 30.1. Toxicology Drug Screening Market Competitive Landscape
• 30.2. Toxicology Drug Screening Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Toxicology Drug Screening Market Other Major And Innovative Companies

• 31.1. BD Bioscience
• 31.2. Quest Diagnostics
• 31.3. ICON plc
• 31.4. Agilent Technologies Inc.
• 31.5. Eurofins Scientific SE
• 31.6. Wuxi AppTec
• 31.7. Charles River Laboratories International Inc.
• 31.8. Shimadzu Corporation
• 31.9. Waters Corporation
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Bruker Corporation
• 31.12. Evotec AG
• 31.13. Promega Corporation
• 31.14. The Jackson Laboratory
• 31.15. Clinical Reference Laboratory Inc.

32. Global Toxicology Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Toxicology Drug Screening Market

34. Recent Developments In The Toxicology Drug Screening Market

35. Toxicology Drug Screening Market High Potential Countries, Segments and Strategies

• 35.1 Toxicology Drug Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Toxicology Drug Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Toxicology Drug Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer